Wafergen Bio-systems (WGBS) Narrows Q3 Loss

Wafergen Bio-systems (NASDAQ: WGBS) reported Q3 EPS of ($1.32), versus ($43.51) reported last year. Revenue for the quarter came in at $1.3 million, versus $389 thousand reported last year.

For earnings history and earnings-related data on Wafergen Bio-systems (WGBS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
• Vireo Growth completes acquisition of C21 Investments